WEGOVY APPROVED TO CUT HEART DISEASE AND STROKE RISK

The maker of Ozempic and Wegovy has received government approval to sell its products to reduce the risk of heart attack,

[{"selector":"#anim-2377de3a-9c42-4c1a-b301-6326faeb8652 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.265120854059415%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

heart disease, and stroke, which might increase insurance coverage for the popular treatments.

[{"selector":"#anim-661c88bf-8ba5-4444-b66e-d2eacd6b516c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.235351448636845%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

The FDA revealed in a press release that Novo Nordisk, the Danish firm behind the insanely popular weight loss injectables,

[{"selector":"#anim-8b4c8fdf-70a8-4f1c-b7da-ab086b0f08ad [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.18723166370539%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

[{"selector":"#anim-08f3d499-c35f-4f48-afcc-1461342fa27a [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-28.93181805397727%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] has received the first heart health approval for overweight or obese adults.

[{"selector":"#anim-88d9e5de-8f5a-4389-ba12-2a3d2d1cf396 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.179687404002955%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Wegovy is the first weight loss medicine licensed to prevent life-threatening cardiovascular events in individuals

[{"selector":"#anim-32087671-6652-4c76-b145-5baefbb07930 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.240844612732676%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] with cardiovascular disease and obesity or overweight," explained FDA diabetes and obesity czar John Sharre tts in a news statement.

[{"selector":"#anim-0e686d52-7786-48d6-8971-c05c8684bb62 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.179687404002955%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] This patient group has an increased risk of heart attack, stroke, and cardiovascular death.

[{"selector":"#anim-02fedb93-7a37-4865-8341-542bbd5401f7 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.179687404002955%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":4000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Providing a proven cardiovascular risk-lowering therapy is a big public health breakthrough."

WEGOVY APPROVED TO CUT HEART DISEASE AND STROKE RISK

The maker of Ozempic and Wegovy has received government approval to sell its products to reduce the risk of heart attack,

heart disease, and stroke, which might increase insurance coverage for the popular treatments.

The FDA revealed in a press release that Novo Nordisk, the Danish firm behind the insanely popular weight loss injectables,

Sean Ono Lennon’s 2024 Oscars Speech Wishes Mom Yoko Happy Mother’s Day

Thanks for watching